Artemis Medicare Services Ltd.
Snapshot View

67.85 -2.80 ▼-4.0%

27 January 2023, 04:01:00 PM
Volume: 18,686

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.artemishospitals.com
Market Cap 907.31 Cr.
Enterprise Value(EV) 1,065.45 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.78 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 24.40 Trailing Twelve Months Ending 2022-09
Industry PE 47.03 Trailing Twelve Months Ending 2022-09
Book Value / Share 23.30 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.91 Calculated using Price: 67.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 13.41 Cr. 134,118,750 Shares
FaceValue 1
Company Profile
The Company is engaged in the business of managing and operating of multi specialty hospitals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.96%
1 Week
-6.80%
1 Month
-8.31%
3 Month
+7.02%
6 Month
+26.23%
1 Year
+55.62%
2 Year
+220.35%
5 Year
10 Year
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 9.50 8.43 2.46 11.66
Return on Capital Employed (%) 13.96 12.64 5.63 11.47
Return on Assets (%) 3.68 3.41 1.03 4.70

Balance Sheet View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 293 313 320 359 379
Non Curr. Liab. 84 115 168 227 233
Curr. Liab. 177 158 118 138 189
Minority Int. 0 0 2 2 5
Equity & Liab. 554 586 609 726 806
Non Curr. Assets 442 469 499 599 640
Curr. Assets 113 118 109 127 166
Misc. Exp. not W/O
Total Assets 554 586 609 726 806

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 547 565 408 555 648
Other Income 4 5 4 4 6
Total Income 551 570 412 559 654
Total Expenditure -483 -504 -373 -487 -571
PBIDT 68 66 39 71 83
Interest -11 -13 -13 -12 -16
Depreciation -20 -23 -22 -22 -26
Taxation -16 -11 -1 -6 -5
Exceptional Items 3
PAT 20 19 6 31 37
Minority Interest 0 0 0 0 1
Share Associate
Other Related Items
Consolidated Net Profit 20 20 6 32 37
Adjusted EPS 2 0 2 3

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 40 56 27 60
Cash Fr. Inv. -50 -26 -37 -107
Cash Fr. Finan. 14 -27 18 44
Net Change 5 2 8 -3
Cash & Cash Eqvt 9 12 19 16

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 69.82 69.82 69.82 69.82 69.82 69.82 69.59 69.27 68.92
Public 30.18 30.18 30.18 30.18 30.18 30.18 30.41 30.73 31.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 25 Jan 2023
Board Meeting Intimation for Board Meeting Intimation For Quarterly Results
Artemis Medicare Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2023 inter alia to consider and approve In pursuance of Regulation 29 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on February 1 2023 (Wednesday) inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/nine months period ended December 31 2022.As informed by our communication dated December 30 2022 the trading window for dealing in securities of the Company was closed from January 1 2023 and shall remain closed till 48 hours after the declaration of financial results i.e. up to February 3 2023 (both days inclusive).
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
we are enclosing herewith the certificate issued by Alankit Assignments Limited Registrar and Transfer Agent of the Company confirming the compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022.
Fri, 30 Dec 2022
Closure of Trading Window
It is hereby informed that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and pursuant to the Companys Code of Conduct to Regulate Monitor and Report Trading in the securities of the Company by Designated Persons and their Immediate Relatives the trading window for trading in securities of the Company shall remain closed for all Concerned Persons with effect from January 1 2023 till 48 hours after the declaration of financial results of the Company for the quarter ending December 31 2022.

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Artemis Medicare Services Ltd.

What is Artemis Medicare share price?

Can I buy Artemis Medicare shares now?

What is the Market Cap of Artemis Medicare?

What are the key metrics to analyse Artemis Medicare?

What is the 52 Week High and Low of Artemis Medicare?

What is the trend of Artemis Medicare share price?